Healthcare, Pharma & Life Sciences

IVD Quality Control Market to Hit $2.2B by 2031 as Labs Go Digital

Image
IVD Quality Control Market to Hit $2.2B by 2031 as Labs Go Digital

Sheridan, Wyo. – October 05, 2026 -- The global in vitro diagnostics (IVD) quality control market is set to climb from $1.7 billion in 2026 to $2.2 billion by 2031, a 5.3% compound annual growth rate, according to a new study by Wissen Research.

Rising testing volumes and regulatory pressure push labs toward automated QC

Growth is driven by expanding testing complexity across clinical chemistry, immunoassay, hematology, and molecular diagnostics, combined with tightening regulatory requirements such as CLIA in the United States. Laboratories are increasingly adopting internal quality controls, third-party control materials, and external quality assessment programs as standard practice.

Michael Jordan Gives UNC Social Work School Record $10 Million

Image
Michael Jordan Gives UNC Social Work School Record $10 Million

Chapel Hill, N.C. – – October 05, 2026 -- Michael Jordan has committed $10 million to the University of North Carolina School of Social Work, the largest single gift in the school's history, honoring his mother Deloris P. Jordan and funding scholarships, research centers and workforce development initiatives.

Gift renames global research center after Deloris P. Jordan

The commitment will rename the Global Social Development Innovations Center, established in 2017, as the Deloris P. Jordan Global Social Development Innovations Center. The center designs and evaluates evidence-based interventions for youth and family well-being in partnership with local organizations worldwide.

Zydus, MSN Launch First Generic Riociguat in U.S. Market

Image
Zydus, MSN Launch First Generic Riociguat in U.S. Market

Ahmedabad – – October 05, 2026 -- Zydus Lifesciences Limited, in partnership with MSN Laboratories Private Limited, has launched the first generic version of riociguat in the United States, undercutting a branded drug whose maker, Bayer, reported approximately EUR 745 million (roughly USD 850 million) in global sales for 2025.

FDA clears five generic strengths matching Adempas

The U.S. Food and Drug Administration approved Riociguat Tablets in 0.5 mg, 1 mg, 1.5 mg, 2 mg and 2.5 mg doses as generic equivalents of Bayer's Adempas Tablets across all strengths. MSN developed and manufactures the product, while Zydus handles U.S. commercialization.

Truth Initiative Names Harvard's Vaughan Rees Chief Research Officer

Image
Truth Initiative Names Harvard's Vaughan Rees Chief Research Officer

Washington – October 05, 2026 -- Truth Initiative, the largest U.S. nonprofit focused on nicotine addiction prevention, has named Dr. Vaughan Rees as Chief Research Officer effective October 27, succeeding Dr. Barbara Schillo.

Harvard tobacco control director takes over Schroeder Institute research arm

Rees joins from Harvard T.H. Chan School of Public Health, where he has directed the Center for Global Tobacco Control since 2015 and served as Senior Lecturer on Social and Behavioral Sciences. He will lead the Schroeder Institute, Truth Initiative's scientific enterprise, overseeing a research portfolio spanning tobacco and nicotine, addiction science, behavioral health, emerging nicotine products, cannabis and polysubstance use.

Function Health Names Ex-Instagram, Uber, Spotify Exec Taj Alavi as First CMO

Image
Function Health Names Ex-Instagram, Uber, Spotify Exec Taj Alavi as First CMO

Austin – October 05, 2026 -- Function Health has appointed Taj Alavi as its first Chief Marketing Officer, tasking the former Instagram, Uber and Spotify executive with scaling consumer adoption of its preventive health testing platform.

Alavi brings three consumer-tech scale-up track records to a health startup

At Instagram, Alavi led global brand marketing and launched the Stories feature as the platform grew from 300 million to 1 billion users. She later ran global brand and creative at Uber before serving as Global Head of Marketing at Spotify, overseeing growth, product and marketing for a $13 billion business spanning music, podcasts and audiobooks. She most recently consulted for Neko Health, a European health-screening company.

Utah Mandates Signed AI Receipts for Clinical Sandbox Vendors via Glacis

Salt Lake City – October 05, 2026 -- Glacis Technologies Inc. has signed a memorandum of understanding with Utah's Office of Artificial Intelligence Policy (OAIP) that makes cryptographically signed AI "receipts" a mandatory condition for vendors and systems operating in the state's Artificial Intelligence Learning Laboratory.

Utah requires a signed receipt for every covered AI inference or safety control evaluation

Under the agreement, designated vendors must generate and deliver a verifiable receipt for every covered AI inference or associated safety and governance control event. The receipts are produced using Glacis technology and mapped to OVERT, an open standard for verifiable evidence of AI operations. OAIP determines which vendors, systems and events fall under the requirement and enforces it through applicable agreements or written designations.

AIRS Medical Wins FDA Clearance for 5-Minute MRI Body Composition Tool

Image
AIRS Medical Wins FDA Clearance for 5-Minute MRI Body Composition Tool

Chicago – October 05, 2026 -- AIRS Medical has secured U.S. FDA 510(k) clearance for SwiftSight Body Composition, an AI-powered MRI analysis tool that quantifies muscle and fat tissue in under five minutes, with SimonMed Imaging confirmed as the first customer to deploy the system.

Scan time under five minutes targets high-volume imaging centers

SwiftSight Body Composition pairs a sub-five-minute MRI scan with automated AI segmentation to measure visceral and subcutaneous fat, abdominal and thigh muscle quantity and quality, bilateral muscle balance, and liver fat via proton density fat fraction. Results are benchmarked against age- and sex-matched reference populations and compiled into a standardized Body Composition Report combining measurements, percentile rankings and visual summaries.

AlloSource Launches UroConnex Fascia for Women's Health Surgery

Image
AlloSource Launches UroConnex Fascia for Women's Health Surgery

Centennial, Colo. – – October 05, 2026 -- AlloSource has added UroConnex Fascia, a human fascia allograft, to its women's health portfolio, targeting urogynecological procedures with an off-the-shelf alternative to autologous fascia.

UroConnex offers surgeons freeze-dried and frozen formats across multiple sizes

The allograft is designed to provide structural support at surgical sites and streamline procedures while reducing patient risk compared to harvesting a patient's own fascia tissue. AlloSource says the product features ideal handling characteristics for precision placement and a natural feel.

Terminal sterilization reduces infection risk to a 10-6 sterility assurance level

The tissue is terminally sterilized through irradiation, according to data on file at AlloSource, aimed at minimizing infection risk in surgical applications.

AI Protein Engineering Market to Hit $3.82B by 2031, MarketsandMarkets Says

Image
AI Protein Engineering Market to Hit $3.82B by 2031, MarketsandMarkets Says

Delray Beach, Fla. – October 05, 2026 -- The global AI in Protein Engineering market will climb to USD 3.82 billion by 2031 from USD 1.44 billion in 2026, a 21.6% compound annual growth rate, according to a new forecast from MarketsandMarkets.

North America holds 48.6% market share as software platforms dominate spending

North America led the market with a 48.6% share in 2025. Software and platforms accounted for 75.4% of revenue the same year, as pharmaceutical and biotech firms prioritized AI-driven design tools over services. Within protein types, miniproteins are set to post the fastest growth at 23.7% CAGR through 2031.

Golden State Dermatology Enters Utah via St. George Acquisition

Image
Golden State Dermatology Enters Utah via St. George Acquisition

St. George, Utah – October 05, 2026 -- Golden State Dermatology (GSD) has expanded into Utah for the first time, adding St. George Dermatology to its physician-led network in a move marking the company's entry into the state.

GSD adds first Utah location through St. George Dermatology partnership

The practice, located in St. George's Ventana Medical Park, offers medical and cosmetic dermatology services including skin cancer screenings, surgical treatments, BOTOX Cosmetic, dermal fillers, chemical peels and laser treatments.

Dr. Daren Brooks returns to hometown practice after running Arizona clinic

Physician Daren Brooks, DO, founded St. George Dermatology after previously operating a dermatology clinic in Arizona. His background spans dermatology, nutrition, stress management and mind-body medicine; he also helped bring the Ironman competition to St. George.